Citation Impact
Citing Papers
Metastasis: from dissemination to organ-specific colonization
2009 Standout
Heparin-Protein Interactions
2002 Standout
Physical Principles of Membrane Shape Regulation by the Glycocalyx
2019 StandoutNobel
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
Further characterization of platelet‐aggregating cysteine proteinase activity in thrombotic thrombocytopenic purpura
1994
Chronic Venous Disease
2006 Standout
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Pro-resolving lipid mediators are leads for resolution physiology
2014 StandoutNature
Cancer Metastasis: Building a Framework
2006 Standout
Dissemination and growth of cancer cells in metastatic sites
2002 Standout
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
The correlation between 13-hydroxyoctadecadienoate dehydrogenase (13-HODE dehydrogenase) and intestinal cell differention
1993
Shedding microvesicles: artefacts no more
2009
Interactions between cancer cells and the microvasculature: a rate-regulator for metastasis
1989
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
1992 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Organ-Specific Metastatic Tumor Cell Adhesion and Extravasation of Colon Carcinoma Cells with Different Metastatic Potential
2006
Anti‐CD36 antibodies in thrombotic thrombocytopenic purpura
1994
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
1994 Standout
Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development.
1996
Increased levels of α6 integrins are associated with the metastatic phenotype of human breast cancer cells
1999
Shedding light on the cell biology of extracellular vesicles
2018 Standout
Fibroblast growth factor signalling: from development to cancer
2010 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Tumor interactions with the vasculature: angiogenesis and tumor metastasis
1990
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Duration of Prophylaxis against Venous Thromboembolism with Enoxaparin after Surgery for Cancer
2002 Standout
The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited
2003 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Platelets in inflammation and atherogenesis
2005 Standout
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
1999 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Exosome poly‐ubiquitin inhibits platelet activation, downregulates CD36 and inhibits pro‐atherothombotic cellular functions
2014
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
Sickle-cell disease
2010 Standout
Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency
1999 Standout
Initiation of Platelet Adhesion by Arrest onto Fibrinogen or Translocation on von Willebrand Factor
1996 Standout
Inflammation and cancer: back to Virchow?
2001 Standout
Clinical evaluation of low-molecular-weight heparin (FR-860) on disseminated intravascular coagulation (DIC) - a multicenter co-operative double-blind trial in comparison with heparin -
1993
Identification of the haemoglobin scavenger receptor
2001 StandoutNature
Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate.
1989
Microenvironmental regulation of metastasis
2008 Standout
Increased platelet deposition on atherosclerotic coronary arteries.
1994
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
2012 Standout
Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells
2010 Standout
Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin
1990
Disseminated Intravascular Coagulation
1999 Standout
P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer.
1993
Mechanisms of Bone Metastasis
2004 Standout
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
1997 Standout
The selectins and their ligands
1994 StandoutNobel
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Aspirin for the Primary Prevention of Cardiovascular Events in Women and Men
2006
Platelet–cancer interactions: mechanisms and pharmacology of tumour cell‐induced platelet aggregation
2004
The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions
2006
Role of β3 Integrins in Melanoma Cell Adhesion to Activated Platelets under Flow
1996
Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
1995 Standout
Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura
1998 Standout
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 Standout
Low molecular weight heparin in prevention of perioperative thrombosis.
1992
Experimental systems for analysis of the malignant phenotype
1982
Extracellular vesicles: Exosomes, microvesicles, and friends
2013 Standout
Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes
2016 Standout
Platelet-collagen interaction: is GPVI the central receptor?
2003
Platelets and cancer
2002
Tumor Cell Interactions With the Microvasculature
2001
The Complex Effects of Heparins on Cancer Progression and Metastasis in Experimental Studies
2001
Activation of blood coagulation in cancer: Trousseau's syndrome revisited
1983
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
1998 StandoutScience
Phosphodiesterase 4D is required for β 2 adrenoceptor subtype-specific signaling in cardiac myocytes
2005 StandoutNobel
Clinical Implications of Circulating Angiogenic Factors in Cancer Patients
2001
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Biology and biogenesis of shed microvesicles
2016
COAGULATION DISORDERS IN CANCER
1996
IL-18 regulates IL-1β-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1
2000
Coronary Plaque Disruption
1995 Standout
Low-molecular-weight heparin in the management of Tyrousseau's syndrome
1997
Low-Molecular-Weight Heparins
1997 Standout
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
2009 Standout
Pathophysiologic Implications of Membrane Phospholipid Asymmetry in Blood Cells
1997
Role of Platelets in Tumor Cell Metastases
1981
Immunolabeling of Type IV Collagen, Laminin, and α-Smooth Muscle Actin Cells in the Intima of Normal and Varicose Saphenous Veins
1998
Role of Monocytes in Atherogenesis
2003
Section Review: Cardiovascular & Renal: Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiovascular diseases
1995
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
1994 StandoutScience
Adhesion Mechanisms in Platelet Function
2007
Works of E Bastida being referenced
Cyclic AMP regulation of endothelial cell triacylglycerol turnover, 13-hydroxyoctadecadienoic acid (13-HODE) synthesis and endothelial cell thrombogenecity
1990
Platelet Contribution to the Formation of Metastatic Foci: The Role of Cancer Cell-Induced Platelet Activation
1988
Binding of 13-HODE and 5-, 12- and 15-HETE to endothelial cells and subsequent platelet, neutrophil and tumor cell adhesion
1988
Influence of shear stress on tumor‐cell adhesion to endothelial‐cell extracellular matrix and its modulation by fibronectin
1989
Fatty acid metabolism and cell/cell interactions
1990
Interleukin-1 increases tumor cell adhesion to endothelial cells through an RGD dependent mechanism: in vitro and in vivo studies
1990
Interleukin 1-induced cancer cell/endothelial cell adhesion in vitro and its relationship to metastasis in vivo: role of vessel wall 13-HODE synthesis and integrin expression
1993
Sex-related differences in the effects of aspirin on the interaction of platelets with subendothelium
1986
Platelet Activation Induced by a Human Neuroblastoma Tumor Cell Line Is Reduced by Prior Administration of Ticlopidine
1986
Cell surface sialylation of two human tumor cell lines and its correlation with their platelet-activating activity.
1987
Effects of endothelial cell treatment on 13-HODE and prostacyclin synthesis and its correlation with tumor cell-vascular endothelial cell adhesion.
1991
Development of a Computer Program to Analyze the Parameters of Platelet-Vessel Wall Interaction
1986
Differential effects of interleukin-1 and formylmethionylleucylphenylalanine on chemotaxis and human endothelium adhesivity for A549 tumor cells.
1989
Morphometric evaluation of thrombogenesis by microvesicles from human tumor cell lines with thrombin-dependent (U87MG) and adenosine diphosphate-dependent (SKNMC) platelet-activating mechanisms.
1986
Fibronectin is required for platelet adhesion and for thrombus formation on subendothelium and collagen surfaces
1987
The interaction of platelets, tumor cells, and vascular subendothelium.
1980
Tissue factor in microvesicles shed from U87MG human glioblastoma cells induces coagulation, platelet aggregation, and thrombogenesis
1984
Differing platelet aggregating effects by two tumor cell lines: Absence of role for platelet‐derived ADP
1981
Idiosyncratic platelet responses to human tumour cells
1981 Nature
Fibronectin is required for platelet adhesion and for thrombus formation on subendothelium and collagen surfaces
1987
The role of subendothelial laminin and platelet laminin receptors in haemostasis.
1992
Tumor‐cell‐induced platelet aggregation is a glycoprotein‐dependent and lipoxygenase‐associated process
1987
Differentiation of platelet-aggregating effects of human tumor cell lines based on inhibition studies with apyrase, hirudin, and phospholipase.
1982
Platelets lacking functional CD36 (glycoprotein IV) show reduced adhesion to collagen in flowing whole blood
1993